Thermo Fisher Scientific (TMO)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
$676.94-4.14%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
QuarterlyIQ Insights · TMO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 8.4% |
| Our one-year growth estimate | diamond | 5.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 2.5 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 18 industry peers · Company calendar date is not available
TMO — President transition
Dated 2026-10-30
Executive Vice President — Michael D. Shafer: The filing announces the planned retirement of an Executive Vice President, which is an orderly succession rather than a sudden loss of a top executive.
Why it matters: The project links over one million patient samples with TMO tools. A named new use or customer would show the tie-up moving forward.
Supportive ifTMO or Mayo Clinic names a study, new customer, or product tied to Precure.
Worry ifA company update says the project is paused, ended, or has no next step by the next earnings report.
Why it matters: Q3 organic growth reached 6%, up from 5% in Q2 and 1% in Q1. Another gain would back the growth plan.
Supportive ifQ4 organic revenue growth is 6% or higher year over year.
Worry ifQ4 organic revenue growth falls below 5% year over year.
Why it matters: The filing notes a planned executive retirement. A named successor and handoff date would show the transition is set.
Watch forTMO names Shafer's successor and gives a handoff date in a filing or company release.
Also watch forTMO reports Shafer left before naming a successor, or delays the handoff date.
Why it matters: TMO said it would update its full-year view during the Q3 call. The new range will show how management reads recent growth.
Watch forThe Q3 call or release raises the 2026 revenue or adjusted EPS range from the prior range.
Also watch forThe Q3 call or release cuts the 2026 revenue or adjusted EPS range from the prior range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$105 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $267 loss on $10,000 · 2.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,138 loss on $10,000 · 31.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.